Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN.
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
JCO Oncol Pract. 2020 Jun;16(6):e507-e516. doi: 10.1200/OP.19.00255. Epub 2020 Feb 6.
Gender disparity persists in academic medicine. Female faculty are underrepresented in leadership positions and have lower research output. We studied gender differences in faculty rank and departmental leadership and contributing factors among academic hematologists and oncologists in the United States.
For clinical faculty at 146 hematology or oncology fellowship programs listed in the Fellowship and Residency Electronic Interactive Database, we collected data on demographics, academic rank, and research output using the Doximity and Scopus databases. We compared unadjusted characteristics of men and women by using 2-sided tests and χ tests where appropriate. To predict probability of full professorship or leadership position among men versus women, we performed multivariable logistic regression analysis adjusted for clinical experience in years, number of publications, -index, clinical trial investigator status, National Institutes of Health funding, and workplace ranking (top 20 not).
Two thousand one hundred sixty academic hematologists and oncologists were included. Women composed 21.9% (n = 142) of full professors, 35.7% (n = 169) of associate professors, and 45.4% (n = 415) of assistant professors. Thirty percent (n = 70) of departmental leaders were women. Female faculty, compared with male faculty, had a lower mean -index (12.1 20.9, respectively; < .001) and fewer years of professional experience since fellowship (10 16 years, respectively; < .001). After adjusting for duration of clinical experience, academic productivity, and workplace ranking, the odds of obtaining professorship (odds ratio [OR], 1.05; 95% CI, 0.71 to 1.57; = .85) or divisional leadership (OR, 0.57; 95% CI, 0.20 to 1.58; = .28) for female physicians were not different compared with male physicians.
Gender disparity exists in senior ranks of academic hematology and oncology; however, gender is not a significant predictor in achieving professorship or department leadership position.
学术医学领域仍然存在性别差异。女性教职员工在领导职位和研究成果方面的代表性不足。我们研究了美国血液学和肿瘤学学术人员的教职等级和部门领导中的性别差异以及促成因素。
对于在 Fellowship and Residency Electronic Interactive Database 中列出的 146 个血液学或肿瘤学研究员课程中的临床教员，我们使用 Doximity 和 Scopus 数据库收集了人口统计学、学术等级和研究成果的数据。我们使用双侧 检验和适当的 χ 检验比较了男性和女性的未调整特征。为了预测男性与女性获得正教授或领导职位的概率，我们进行了多变量逻辑回归分析，调整了临床经验年限、出版物数量、H 指数、临床试验研究者身份、美国国立卫生研究院资助和工作场所排名（前 20% 不）。
纳入了 2160 名学术血液学家和肿瘤学家。女性正教授占 21.9%（n=142），副教授占 35.7%（n=169），助理教授占 45.4%（n=415）。30%（n=70）的部门领导是女性。与男性教员相比，女性教员的平均 H 指数较低（分别为 12.1 和 20.9；<.001），专业经验年限较短（分别为 10 年和 16 年；<.001）。在调整了临床经验年限、学术生产力和工作场所排名后，女性医生获得教授职位（优势比[OR]，1.05；95%置信区间，0.71 至 1.57；=.85）或部门领导职位（OR，0.57；95%置信区间，0.20 至 1.58；=.28）的几率与男性医生没有差异。
在血液学和肿瘤学的高级职位中存在性别差异；然而，性别并不是获得教授职位或部门领导职位的重要预测因素。
